Ultrasound-Guided fluid therapy may cut lung risks in elderly cancer surgery

NCT ID NCT07691944

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial investigates whether using a special ultrasound score (VExUS) to guide fluid delivery during surgery can lower the chance of lung complications in patients aged 65–80 undergoing minimally invasive esophageal cancer removal. Participants are randomly assigned to receive either VExUS-guided fluid therapy or standard fluid management. The study tracks lung complications, recovery quality, and hospital stay length to see if the ultrasound-guided approach improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
VExUS score-guided goal-directed fluid therapy (procedure)
What this could lead to
If successful, this approach could reduce serious lung complications after esophageal cancer surgery in elderly patients, potentially improving recovery and shortening hospital stays.
What could go wrong
This is a single-center trial with 126 participants, so results may not apply broadly. The intervention requires specialized ultrasound training, and benefits over standard care may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER (ESC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.